Indeed, there is a second drop in numbers of CD8+CD122+ T cells in the blood and spleen at approximately 1 week after stroke, along with persistent elevation of numbers of brain-infiltrating CD8+CD122+ T cells, suggesting a delayed, antigen-specific function of this population in stroke recovery, but this awaits further study. This evidence concerns the gene CD8A and Stroke.